RIAL
TEVA icon

Rothwell Investment Advisors, LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$158K Buy
+3,990
New +$143K 0.08% 211

Other funds holding TEVA

Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Rothwell Investment Advisors, LLC's TEVA Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 3,990 shares worth $158K. The stake represents 0.08% of the portfolio and ranks #211 among its holdings.

261 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Rothwell Investment Advisors, LLC held 3,990 shares of Teva Pharmaceutical Industries Limited worth $158K as of Q3 2026.
  • Teva Pharmaceutical Industries Limited was a new Rothwell Investment Advisors, LLC position in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up 0.08% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #211 holding.
  • 261 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.